Skip to content

Tuesday, July 8, 2025

Latest:

Healthy Habits: Dr. Roy Williams Jr. starts his day with exercise
Surviving cancer and tracheoesophageal fistula: Sandy Tovey’s journey
Handy ‘MasSpec Pen’ collection could help detect opioids from the skin
A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CALGB 40601 clinical trial

From The Labs

Researchers identified new indicators for HER2+ breast cancer response to therapy

June 17, 2025 Breast Cancer, CALGB 40601 clinical trial, GPRC5A, HER2, proteogenomics, Research, response to treatment, TPBG

Being able to predict the response of cancer to treatment by analyzing a tumor sample before therapy is given would significantly affect clinical outcomes

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma